COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Spectranetics Corporation (Nasdaq:SPNC) today announced an agreement with ThermopeutiX, Inc. to commercialize the TAPAS catheter, a therapeutic infusion ...

Spectranetics recalled more than 1,900 Bridge Occlusion Balloon Catheters due to a product flaw that may prevent the device from working properly. Here are five things to know. 1. Some recalled ...

Consistent with its commitment to eradicating restenosis and amputations, Spectranetics (SPNC) announced the U.S. market launch of the TAPAS catheter at the 2012 Vascular Interventional Advances ...

COLORADO SPRINGS, Colo., Jul 01, 2010 (BUSINESS WIRE) -- Spectranetics Corporation /quotes/comstock/15*!spnc/quotes/nls/spnc (SPNC 5.19, +0.03, +0.58%) today ...

Spectranetics Corp. will pay $24 million for Kensey Nash Corp.'s line of catheters used to treat blood clots in a move to broaden its product line, Spectranetics said today. The Colorado Springs-based ...

July 1 (Reuters) - Spectranetics Corp said it was recalling specific lots of its thrombus extraction catheter due to a manufacturing process issue. The company said the issue may may result in a ...

AngioScore, which makes catheters used to treat cardiovascular and peripheral artery diseases, is being acquired for $230 million by the Spectranetics Corp. The Fremont company led by CEO Thomas R.

"Dr. Kassab's work at Oakwood Hospital further validates the quality-of-life improvements that may be achieved with our CLiRpath excimer laser catheters," said John G. Schulte, president and chief ...

COLORADO SPRINGS, Colo., The Spectranetics Corporation (NASDAQ:SPNC) today announced receipt of U.S. Food and Drug Administration (FDA) 510(k) clearance of its peripheral atherectomy product, the ...

The segment featured the treatment of peripheral vascular disease with Spectranetics' CLiRpath excimer laser catheter at Brigham and Women's Hospital by Dr. Andrew Eisenhauer, and included favorable ...